[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [marketticker...] --------------------------------------------------------------- Sponsor Message [This Govt. Act Can Help Investors]( [See how this new influx of cash could create big investment opportunities]([aff_i?offer_...] --------------------------------------------------------------- November 28, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message ["We need batteries. Literally everywhere."]( [b7d51c88-c8f...](Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense." [Read about this company's once-in-a-lifetime graphite opportunity -- before Wall Street]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [GoHealth, GOCO]( Recent Analyst Action: Ben Hendrix, analyst at RBC Capital, reiterates coverage on [GoHealth (GOCO)](in the Financial sector with a Hold rating and a price target of $1.00 (1 week ago). - Recent Price: $9.3 - Average Analyst Price Target: $1.00 (-89.25%) - Market Cap: $201.26M [TipRanks.com]( also reports that [GoHealth](currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $1.00. The target pricing ranges from a high forecast of $1.00 down to a low forecast of $1.00. [GoHealth (GOCO)](’s last closing price was $9.3 which would put the average price target at $1.00. Here are 3rd party ratings for [GOCO](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Bottom 20% (200 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Millionaire Investor Reveals: "How I Made My Second Fortune... By Avoiding 99% of Stocks"]( [eb528704-62b...](Buy this small group of unique stocks… never sell them… and make all the money you need… No matter what happens in the market. [Revealed here: the name and ticker of the #1 stock.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Streamline Health Solutions, STRM]( Recent Analyst Action: Brooks O'Neil, analyst at Lake Street, reiterates coverage on [Streamline Health Solutions (STRM)](in the Technology sector with a Buy rating and a price target of $3.00 (1 week ago). - Recent Price: $2.04 - Average Analyst Price Target: $3.00 (47.06%) - Market Cap: $111.83M [TipRanks.com]( also reports that [Streamline Health Solutions](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.00. The target pricing ranges from a high forecast of $3.00 down to a low forecast of $3.00. [Streamline Health Solutions (STRM)](’s last closing price was $2.04 which would put the average price target at $3.00. Here are 3rd party ratings for [STRM](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Paratek Pharmaceuticals, PRTK]( Recent Analyst Action: Ed Arce, analyst at H.C. Wainwright, reiterates coverage on [Paratek Pharmaceuticals (PRTK)](in the Healthcare sector with a Buy rating and a price target of $20.00 (3 weeks ago). - Recent Price: $2.29 - Average Analyst Price Target: $25.00 (991.70%) - Market Cap: $125.54M [TipRanks.com]( also reports that [Paratek Pharmaceuticals](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $25.00. The target pricing ranges from a high forecast of $30.00 down to a low forecast of $20.00. [Paratek Pharmaceuticals (PRTK)](’s last closing price was $2.29 which would put the average price target at $25.00. Here are 3rd party ratings for [PRTK](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 22% (56 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [These 2 Dividend Stocks Pay Every Week]( [bc82e8e3-d6f...](Are you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [BioVie, BIVI]( Recent Analyst Action: Constantine Davides, analyst at EF Hutton, reiterates coverage on [BioVie (BIVI)](in the Healthcare sector with a Buy rating and a price target of $8.00 (2 months ago). - Recent Price: $6.77 - Average Analyst Price Target: $10.00 (47.71%) - Market Cap: $201.82M [TipRanks.com]( also reports that [BioVie](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $8.00. [BioVie (BIVI)](’s last closing price was $6.77 which would put the average price target at $10.00. Here are 3rd party ratings for [BIVI](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 32% (80 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Zevia PBC, ZVIA]( Recent Analyst Action: Andrew Strelzik, analyst at BMO Capital, reiterates coverage on [Zevia PBC (ZVIA)](in the Consumer Goods sector with a Buy rating and a price target of $8.00 (2 weeks ago). - Recent Price: $4.09 - Average Analyst Price Target: $5.80 (41.81%) - Market Cap: $265.86M [TipRanks.com]( also reports that [Zevia PBC](currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.80. The target pricing ranges from a high forecast of $8.00 down to a low forecast of $3.50. [Zevia PBC (ZVIA)](’s last closing price was $4.09 which would put the average price target at $5.80. Here are 3rd party ratings for [ZVIA](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Bottom 43% (144 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message ["TAKE THAT, CHINA!" USA Gains in EV Battery Arms Race]( [f49ed5bd-118...](Did you know each electric car battery requires 220 pounds of graphite - more than lithium, copper, or aluminum? China enjoyed a "near monopoly" in this vital ingredient... until the U.S. made a blockbuster announcement. Now one little-known company is set to play a crucial role in the booming $7 trillion EV revolution. [Get the full story on this new North American graphite opportunity]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Ocuphire Pharma, OCUP]( Recent Analyst Action: Sean Kim, analyst at JonesTrading, reiterates coverage on [Ocuphire Pharma (OCUP)](in the Healthcare sector with a Buy rating and a price target of $16.00 (5 days ago). - Recent Price: $3.15 - Average Analyst Price Target: $21.75 (590.48%) - Market Cap: $64.69M [TipRanks.com]( also reports that [Ocuphire Pharma](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $21.75. The target pricing ranges from a high forecast of $26.00 down to a low forecast of $16.00. [Ocuphire Pharma (OCUP)](’s last closing price was $3.15 which would put the average price target at $21.75. Here are 3rd party ratings for [OCUP](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 22% (56 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Safe-T Group, SFET]( Recent Analyst Action: Jason Kolbert, analyst at Dawson James, reiterates coverage on [Safe-T Group (SFET)](in the Technology sector with a Buy rating and a price target of $6.00 (2 months ago). - Recent Price: $3.3 - Average Analyst Price Target: $6.00 (81.82%) - Market Cap: $10.36M [TipRanks.com]( also reports that [Safe-T Group](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $6.00. The target pricing ranges from a high forecast of $6.00 down to a low forecast of $6.00. [Safe-T Group (SFET)](’s last closing price was $3.3 which would put the average price target at $6.00. Here are 3rd party ratings for [SFET](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 24% (60 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Without Graphite, There Would Be ZERO EV Batteries!]( [f04decf1-4eb...](Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients. [See This Special Report to Get the Full Story]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software